Key Takeaways
- A meta-analysis of 6 randomized controlled trials (546 participants) found nattokinase supplementation reduced systolic blood pressure by 3.45 mmHg and diastolic by 2.32 mmHg — modest but clinically meaningful
- The most-studied dose is 2,000 FU (Fibrinolytic Units) per day, with blood pressure effects typically appearing after 8 weeks of daily use
- Nattokinase should never be combined with blood thinners (warfarin, heparin) or antiplatelet drugs without medical supervision — case reports document serious complications including fatal bleeding
- Japanese manufacturers have developed vitamin K2 removal technology (NSK-SD), addressing a critical safety concern for cardiovascular patients that many international supplements don't account for
- The largest prevention trial (NAPS) found no significant benefit in healthy adults — nattokinase appears most effective in people with existing cardiovascular risk factors
- The Japan Nattokinase Association (JNKA) provides quality certification that has no equivalent in other supplement markets
You've read the health forum posts. Someone swears nattokinase cleared their arteries. Another says it replaced their blood pressure medication. A third is terrified about blood thinning risks. If you're trying to make an informed decision about nattokinase, the signal-to-noise ratio is not in your favor.
Nattokinase reviews online range from breathless endorsements to vague warnings, with very few stopping to ask the question that actually matters: what does the clinical evidence show?
We reviewed over 20 clinical studies, meta-analyses, and systematic reviews — including Japanese research rarely cited in English-language guides — to build this assessment. The evidence tells a more nuanced story than most reviews suggest. Nattokinase has genuine, measurable effects on blood pressure and fibrinolytic activity. It also has real safety concerns that most product pages gloss over. And the gap between what clinical trials demonstrate and what forum users claim is worth understanding.
This guide covers the clinical data behind nattokinase, what users actually report, how to evaluate supplement quality (including Japanese quality markers like JNKA certification and vitamin K2 removal technology), and where the evidence is still catching up to the hype. Whether you're considering nattokinase for cardiovascular support or simply trying to figure out if it's worth your money, this is the review you need before buying.
What Is Nattokinase?
Nattokinase is a fibrinolytic enzyme extracted from natto, a traditional Japanese food made by fermenting soybeans with Bacillus subtilis var. natto. Natto has been consumed in Japan for over 1,000 years, but the specific enzyme responsible for its cardiovascular effects was only identified in the late 1980s, when a researcher at the University of Chicago placed natto on artificial fibrin in a petri dish and observed potent clot-dissolving activity [21].
The discovery was significant: nattokinase demonstrated the highest fibrinolytic activity among 173 different foods tested [2]. A single serving of natto (100g) contains fibrinolytic activity equivalent to approximately 200,000 units of urokinase, a pharmaceutical thrombolytic agent used in hospitals [19].
With a molecular weight of approximately 27.7 kDa, nattokinase is a subtilisin-like serine protease — a category of enzyme that specifically targets and breaks down fibrin, the protein that forms the structural scaffolding of blood clots [2]. But the enzyme's story extends well beyond simple clot dissolution, as recent research has revealed multiple mechanisms of action.
How Nattokinase Works: The Science
Fibrinolytic Activity
Nattokinase works through a dual mechanism that distinguishes it from pharmaceutical blood thinners. First, it directly cleaves cross-linked fibrin — physically breaking down the protein mesh that holds clots together. Second, it activates the body's own clot-dissolving system by converting plasminogen to plasmin through tissue plasminogen activator (t-PA) activation, while simultaneously inactivating plasminogen activator inhibitor-1 (PAI-1) — essentially removing the brakes on your body's natural fibrinolytic system [2].
A critical safety finding: the hemorrhagic safety margin of nattokinase is three times that of t-PA, the pharmaceutical thrombolytic used in emergency medicine [1]. This wider safety margin is one reason nattokinase has attracted sustained research interest as a supplement.
One question that matters for supplement efficacy: can nattokinase survive digestion and reach the bloodstream intact? A pharmacokinetic study confirmed that nattokinase is absorbed through the intestinal tract and detectable in blood within 30 minutes of oral intake, with fibrinolytic effects peaking between 4 and 13 hours [2].
Understanding FU (Fibrinolytic Units)
FU — Fibrinolytic Units — measure nattokinase's clot-dissolving potency, yet few supplement reviews explain what this number actually means. One FU equals the amount of enzyme that generates 1 micrograms of plasmin per minute under standard conditions. Clinical trials predominantly use doses of 2,000 FU per day, though some Japanese supplements offer 4,000 FU for higher potency.
When comparing nattokinase supplements, FU is the metric that matters — not milligrams. Two supplements containing the same weight of nattokinase powder can have vastly different FU ratings depending on the enzyme's purity and activity. A supplement listing "100 mg nattokinase" without an FU value provides incomplete information about its actual potency.
Beyond Blood Thinning
Recent research has identified nattokinase effects that extend beyond fibrinolysis. The enzyme demonstrates anti-inflammatory properties, reducing tumor necrosis factor-alpha (TNF-a), interleukin-6 (IL-6), and interleukin-8 (IL-8) in preclinical studies [7]. Emerging evidence also suggests potential for lipid modification and amyloid fibril degradation — the latter being investigated for possible Alzheimer's disease implications [2]. These areas remain in early research stages, but they explain why nattokinase research interest has expanded beyond cardiovascular applications.
Evidence-Based Benefits
Blood Pressure Reduction: Strong Evidence
Blood pressure is nattokinase's strongest evidence area, supported by multiple randomized controlled trials and a recent meta-analysis.
The most comprehensive analysis pooled data from 6 RCTs involving 546 participants and found nattokinase significantly reduced systolic blood pressure by 3.45 mmHg (95% CI: -5.92 to -0.98, p<0.01) and diastolic blood pressure by 2.32 mmHg (95% CI: -3.67 to -0.97, p<0.001) [1]. These reductions are modest compared to prescription medications but clinically meaningful — comparable to what some lifestyle interventions achieve for mild hypertension.
A multicenter, double-blind, placebo-controlled trial in North American subjects with hypertension confirmed these findings. Participants taking 2,000 FU daily experienced significant reductions in both systolic and diastolic blood pressure, along with decreased von Willebrand factor (vWF), a cardiovascular risk marker [3].
In patients with stable coronary artery disease, a more recent RCT found even larger effects: 2,000 FU per day for 90 days reduced systolic blood pressure by 5.3 mmHg and diastolic by 3.1 mmHg compared to placebo [4].
Key context: Effects are typically seen after 8 weeks of daily supplementation [1]. Nattokinase appears most effective in people who already have elevated blood pressure, not as a preventive measure in those with normal readings.
Blood Clot Prevention and Cardiovascular Health: Moderate Evidence
Nattokinase's fibrinolytic properties are well-documented in laboratory and small human studies, but large-scale prevention trials present a more complex picture.
A comprehensive review of 10 clinical studies concluded that nattokinase has "potent fibrinolytic activity, antihypertensive, anti-atherosclerotic, and lipid-lowering effects" with a favorable safety profile [2]. A real-world safety study that followed patients with vascular diseases taking nattokinase reported no adverse events and confirmed decreased systolic blood pressure during supplementation [8].
However, the largest prevention RCT tells a different story. The Nattokinase Atherothrombotic Prevention Study (NAPS) — a randomized controlled trial in healthy adults — found nattokinase did not significantly differ from placebo for atherothrombotic prevention on primary endpoints [5]. This is a critical finding: nattokinase's strongest effects appear in people with existing cardiovascular risk factors, not as a general preventive in healthy populations.
A comparison review of novel oral anticoagulants (NOACs) versus nattokinase noted that nattokinase offers the advantages of oral bioavailability and lower bleeding risk compared to pharmaceutical anticoagulants, though it should not be considered a replacement for prescribed medications [9].
Cholesterol and Lipid Profile: Emerging Evidence
The evidence for nattokinase's effects on cholesterol is mixed and notably weaker than the blood pressure data.
The meta-analysis surprisingly found that nattokinase at low doses may slightly increase total cholesterol rather than decrease it, with negative effects on HDL cholesterol. High heterogeneity across studies limits firm conclusions [1].
An RCT investigating nattokinase alone at 2,000 FU per day for 90 days found no significant cholesterol improvements versus placebo. However, when nattokinase was combined with red yeast rice, lipid improvement trends appeared [4]. Similarly, a trial of nattokinase-Monascus combination supplements showed improved dyslipidemia over 4 months — but it was the combination, not nattokinase alone, driving the effect [6].
Bottom line: If your primary goal is cholesterol management, the current evidence does not support nattokinase as a standalone solution. Blood pressure reduction is a much stronger evidence area for this supplement.
Atherosclerotic Plaque Reduction: Preliminary Evidence
"Can nattokinase unclog arteries?" is one of the most frequently searched questions about this supplement. The honest answer: the evidence is very early.
One study reported that after 12 months of nattokinase consumption, carotid artery plaque size decreased by 36.6% (from 1.33 to 1.04mm on average, P<0.001), compared to 11.5% progression in the control group. This is an intriguing finding, but it comes from a single study.
The definitive answer may come from an ongoing Phase 2 RCT at the University of Southern California (NCT02080520), which is following 240 healthy adults over 3 years, measuring changes in carotid intima-media thickness and arterial stiffness with 2,000 FU/day nattokinase versus placebo [14]. Until those results are published, plaque reduction claims should be treated as preliminary.
What Users Actually Report
Understanding real-world user experiences adds context to clinical data — though anecdotal reports cannot replace controlled evidence. Across nattokinase reviews on health platforms and forums, several consistent patterns emerge.
Most common positive reports:
- Blood pressure improvements are the most frequently mentioned benefit across user review platforms
- Post-COVID symptom improvement — fatigue, palpitations, and exercise intolerance — has emerged as a notable pattern in user communities
- Improved circulation and energy are common themes
- Blood work improvements, particularly lower inflammatory markers
Most common concerns:
- Blood thinning effects and uncertainty about safety
- Questions about interactions with prescribed medications
- Whether nattokinase can replace prescribed blood thinners (it cannot)
- Dosage confusion — particularly around FU units
Important context: User reviews are subject to selection bias. People with dramatic experiences — positive or negative — are more likely to post. The post-COVID benefits reported by users have not been validated in clinical trials. No RCTs have evaluated nattokinase specifically for long COVID symptoms, so these remain anecdotal observations.
How to Choose a Nattokinase Supplement
Key Quality Markers
Not all nattokinase supplements are equivalent. One point most nattokinase reviews overlook is the specific quality markers that distinguish effective supplements from inadequate ones:
| Quality Marker | What to Look For | Why It Matters |
|---|---|---|
| FU Potency | 2,000-4,000 FU per serving, clearly stated | Clinical trials use 2,000 FU/day. "mg" without FU tells you nothing about actual enzyme activity |
| Vitamin K2 Status | Confirmed vitamin K2 removal (e.g., NSK-SD) | Natto naturally contains vitamin K2, which promotes clotting — the opposite of nattokinase's effect. Critical for anticoagulant users |
| JNKA Certification | Japan Nattokinase Association (JNKA) certification mark | Verifies purity, activity levels, and standardized quality. No equivalent exists in other markets |
| Third-party Testing | NSF, GMP, or independent lab verification | Ensures the supplement contains what it claims |
| Manufacturing Standard | GMP-certified facility | Consistent quality control in production |
The Vitamin K2 Paradox
This is a point most reviews miss entirely. Natto — the food from which nattokinase is extracted — naturally contains vitamin K2 (menaquinone-7), which promotes blood clotting. This means a nattokinase supplement that retains vitamin K2 is simultaneously thinning blood (via nattokinase) and promoting clotting (via K2). For healthy people this may balance out, but for anyone taking anticoagulants like warfarin, vitamin K2 in the supplement can directly interfere with their medication [18].
Japanese manufacturers developed technology to remove vitamin K2 from nattokinase supplements — the most well-known being the NSK-SD formulation. This is a practical quality differentiator when evaluating supplements [19].
Dosage and How to Take Nattokinase
| Parameter | Evidence-Based Guidance |
|---|---|
| Standard dose | 2,000 FU/day (approximately 100 mg) — most-studied dose across RCTs |
| High-potency option | 4,000 FU/day — used in some Japanese supplements; safety confirmed |
| Maximum tested safe dose | 10,000 FU/day (5x recommended) — no adverse effects in safety trial [20] |
| Time to blood pressure effects | Typically 8 weeks of daily use |
| Acute fibrinolytic activity | Detectable within 30 minutes, peaks at 4-13 hours |
| Cardiovascular marker changes | 90 days in clinical trials |
| Timing | Limited evidence on optimal timing. Some practitioners suggest empty stomach for absorption, but no RCT has compared timing protocols |
| Form | Capsules are most studied. No significant evidence favoring one form over another |
Important: These are dosages used in research settings. Starting at 2,000 FU per day is a reasonable approach based on the evidence. Higher doses should be discussed with a healthcare provider, particularly if you take any medications affecting blood coagulation.
Safety Considerations
Nattokinase has a generally favorable safety profile in clinical trials, but several critical concerns deserve careful attention.
Side Effects
Clinical trials consistently report no major adverse events at standard doses (2,000 FU/day). The meta-analysis of 6 RCTs noted: "No notable adverse events were reported in all studies" [1]. Minor side effects documented include:
- Mild gastrointestinal issues (nausea, diarrhea, stomach upset) — typically resolve without intervention [15]
- One trial noted a slight increase in blood glucose versus placebo [1]
- Nattokinase has been confirmed nonmutagenic and nonclastogenic in laboratory studies [2]
The NSK-SD formulation has passed single-dose toxicity, repeated-dose toxicity, and genotoxicity testing. An overingestion safety study confirmed safety at 10,000 FU/day — five times the recommended dose [20].
Drug Interactions
This is where nattokinase safety becomes critical.
| Medication Class | Risk Level | Details |
|---|---|---|
| Anticoagulants (warfarin, heparin) | High | Significantly increases bleeding risk through additive blood-thinning effects. Do not combine without medical supervision [15] |
| Antiplatelet drugs (aspirin, clopidogrel) | High | Additive bleeding risk through complementary mechanisms [12] |
| Blood pressure medications | Moderate | Additive hypotensive effects are theoretically possible. Monitor blood pressure if combining |
| Other blood-thinning supplements (fish oil, vitamin E, garlic) | Moderate | May compound bleeding risk [15] |
| Fibrinolytic medications | High | Theoretical potentiation of fibrinolytic effects |
Who Should Avoid Nattokinase
- Anyone on anticoagulant therapy without explicit medical supervision [15]
- People with active bleeding disorders or coagulation disorders
- Pre-surgery patients — discontinue at least 1 week before any surgery, including dental procedures
- People with allergy to fermented soybeans or natto
Serious Adverse Event Reports
Despite the overall favorable safety data from clinical trials, case reports document serious complications that underscore why medical supervision matters:
- Internal bleeding resulting in death in an elderly woman taking nattokinase for atrial fibrillation [16]
- Thrombosis on a mechanical heart valve after a patient self-substituted nattokinase for prescribed warfarin [16]
- Severe allergic reactions in patients allergic to fermented soybeans
Nattokinase is not a replacement for prescribed medications. These cases are rare but reinforce that nattokinase should complement — never replace — prescribed cardiovascular therapies.
Pregnancy and Nursing
No clinical data exists. No studies have evaluated nattokinase safety during pregnancy or breastfeeding. Given the enzyme's blood-thinning properties, avoiding nattokinase during pregnancy and nursing — or consulting a healthcare provider — is the prudent approach.
Beyond the Label: What Japanese Research Adds to the Nattokinase Story
Most nattokinase reviews draw exclusively from English-language studies. Here are insights from Japanese research that add meaningful context to the evidence.
The Vitamin K2 Removal Innovation
Natto naturally contains vitamin K2, a nutrient that promotes blood clotting — creating a paradox in nattokinase supplements. Japanese manufacturers recognized this issue and developed extraction technology (most notably the NSK-SD process) that removes vitamin K2 while preserving nattokinase activity [18]. Many international nattokinase products don't specify whether vitamin K2 has been removed.
Why this matters: For anyone taking anticoagulants — or anyone choosing nattokinase specifically for its blood-thinning properties — a supplement containing vitamin K2 partially counteracts the intended effect. This formulation detail can change whether a supplement helps or hinders.
A Quality Certification System With No International Equivalent
The Japan Nattokinase Association (JNKA) provides a certification program that verifies nattokinase supplement purity and activity levels [17]. JNKA-certified products carry a certification mark assuring consumers of standardized quality. No equivalent certification body exists in the U.S. or European supplement markets.
Why this matters: In supplement markets where third-party testing is voluntary and inconsistent, JNKA certification provides an additional quality assurance layer specifically designed for nattokinase.
High-Dose Safety Data Published in Japan
While most English-language reviews cover standard dosing, Japanese researchers have conducted safety testing at significantly higher levels. The NSK-SD formulation was tested at 10,000 FU per day (5x the recommended dose) in a registered clinical trial, with no adverse effects reported [20]. This provides a wider safety margin than what's typically cited in international literature.
Why this matters: Understanding the tested upper limit gives context for everyday dosing. If safety is confirmed at five times the standard dose, the 2,000-4,000 FU range used in supplements sits well within established margins.
Beyond Cardiovascular: NK Cell Activation Research
Japanese research from Tokyo Medical University has explored nattokinase's effects on natural killer (NK) cell activation at 4,000 FU doses, suggesting potential immune function benefits beyond the cardiovascular applications that dominate international literature [18]. This research is preliminary and the naming similarity (NK cells vs. nattokinase/NK) is coincidental, but it represents a research direction unique to Japanese studies.
Why this matters: While cardiovascular effects remain the primary reason to consider nattokinase, immune function research may eventually broaden the supplement's evidence-based applications.
A Functional Food Regulatory Framework
In Japan, nattokinase-containing products can qualify as functional foods with health claims (機能性表示食品) — a regulatory category overseen by the Consumer Affairs Agency (消費者庁) that permits specific, evidence-backed health claims on product labels [18]. This regulatory pathway requires manufacturers to submit clinical evidence supporting their claims, creating a higher accountability standard than the U.S. supplement market's structure/function claim system.
Why this matters: Products that have passed Japan's functional food review process carry health claims backed by submitted clinical data — not just generic structure/function statements.
Our Recommendations
Japanese Nattokinase 4000: Premium Blood Circulation Support
Why We Selected This: From ORIHIRO, a well-established Japanese supplement manufacturer. We chose this for customers seeking higher-potency nattokinase because it delivers 4,000 FU per serving — double the most-studied clinical dose. ORIHIRO's manufacturing follows Japanese GMP standards, and the formulation includes complementary DHA and EPA for comprehensive cardiovascular support.
This is the supplement we recommend for those who want maximum fibrinolytic potency from a single product. The 4,000 FU dose aligns with the higher-potency Japanese formulations discussed in the research, and the inclusion of omega-3 fatty acids adds cardiovascular support through a different mechanism than nattokinase alone.
View Japanese Nattokinase 4000 →
Nattokinase EX: Cardiovascular Support Formula
Why We Selected This: From Kobayashi Pharmaceutical, one of Japan's most recognized pharmaceutical companies with over a century of history. We chose this for customers who want nattokinase from a manufacturer with pharmaceutical-grade quality standards. The formulation includes DHA and EPA alongside nattokinase, targeting multiple cardiovascular pathways simultaneously.
Kobayashi's reputation for quality control in pharmaceutical manufacturing carries over to their supplement line, making this a strong choice for those who prioritize manufacturer credibility.
Noguchi Nattokinase HQ: Premium Natto Supplement
Why We Selected This: From the Noguchi Medical Research Institute (NMRI), named after Dr. Hideyo Noguchi, one of Japan's most celebrated medical scientists. We chose this for customers who value a research-oriented brand heritage. The "HQ" (High Quality) designation reflects NMRI's focus on premium formulation and ingredient purity.
For those prioritizing brand heritage and research credibility, Noguchi brings a medical research institute perspective to supplement formulation that distinguishes it from standard supplement manufacturers.
Product Comparison
| Product | Brand | FU Potency | Additional Ingredients | Best For |
|---|---|---|---|---|
| Japanese Nattokinase 4000 | ORIHIRO | 4,000 FU | DHA, EPA | Maximum fibrinolytic potency |
| Nattokinase EX | Kobayashi Pharmaceutical | Standard | DHA, EPA | Pharmaceutical-grade quality assurance |
| Noguchi Nattokinase HQ | NMRI | Standard | — | Research-oriented brand heritage |
Conclusion
Nattokinase occupies an interesting position in the supplement landscape — an enzyme with genuine clinical evidence for blood pressure reduction, real but nuanced cardiovascular effects, and safety considerations that deserve more attention than most nattokinase reviews give them.
The evidence supports nattokinase most strongly for blood pressure management in people with existing hypertension, with a meta-analysis of 6 RCTs confirming significant reductions. Its fibrinolytic properties are well-documented, though the largest prevention trial reminds us that effects are strongest in those with cardiovascular risk factors, not as general prevention.
For those considering nattokinase, three things matter most: choosing a supplement with clearly stated FU potency (2,000-4,000 FU), understanding whether vitamin K2 has been removed (critical for anticoagulant users), and recognizing that this supplement complements but never replaces prescribed cardiovascular medications. Japanese quality standards — JNKA certification, high-dose safety testing, and vitamin K2 removal technology — offer practical quality markers worth looking for.
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new health regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials
- Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases
- Blood pressure and von Willebrand factor: results from a multicenter North American clinical trial
- Effects of nattokinase combined with red yeast rice in patients with stable coronary artery disease
- Nattokinase atherothrombotic prevention study: a randomized controlled trial
- The effect of Nattokinase-Monascus supplements on dyslipidemia
- Nattokinase as an adjuvant therapeutic strategy for non-communicable diseases
- Data recorded in real life support the safety of nattokinase in patients with vascular diseases
- Comparative cardioprotective effectiveness: NOACs vs. Nattokinase
- Research progress of nattokinase in reducing blood lipids
- Natto and its active ingredient nattokinase: a potent and safe thrombolytic agent
- Dietary supplements, herbs and oral anticoagulants: the nature of the evidence
- Navigating the effects of anti-atherosclerotic supplements and acknowledging associated bleeding risks
- Ongoing USC Phase 2 RCT on nattokinase and atherosclerosis (NCT02080520)
- Nattokinase — safety and interaction monograph
- Nattokinase — uses, side effects, and more
- 日本ナットウキナーゼ協会 — quality certification standards
- ナットウキナーゼの最新研究情報 — safety testing and NK cell research
- 納豆が脳梗塞・心筋梗塞を防ぐ理由 — mechanism and dosage data (doctor-supervised)
